A Study of QL1706 Combined With OH2 Injection in Perioperative Treatment of Stage III Resectable Acral Melanoma (clinicaltrials.gov) - Oct 3, 2026 - P4 | N=76 | Not yet recruiting | Sponsor: Peking University Cancer Hospital & Institute
New P4 trial • Melanoma • Oncology • Solid Tumor
|